BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30700194)

  • 1. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?
    Noergaard M; Traerup Andersen J; Jimenez-Solem E; Bring Christensen M
    Scand J Gastroenterol; 2019 Jan; 54(1):27-34. PubMed ID: 30700194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation.
    Paré P; Fedorak RN
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):549-57. PubMed ID: 25390617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation.
    Kienzle-Horn S; Vix JM; Schuijt C; Peil H; Jordan CC; Kamm MA
    Curr Med Res Opin; 2007 Apr; 23(4):691-9. PubMed ID: 17407625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review.
    Rao SSC; Brenner DM
    Am J Gastroenterol; 2021 Jun; 116(6):1156-1181. PubMed ID: 33767108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTC laxative use of sodium picosulfate â results of a pharmacy-based patient survey (cohort study).
    Hinkel U; Schuijt C; Erckenbrecht JF
    Int J Clin Pharmacol Ther; 2008 Feb; 46(2):89-95. PubMed ID: 18218289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge.
    Whorwell P; Lange R; Scarpignato C
    Therap Adv Gastroenterol; 2024; 17():17562848241249664. PubMed ID: 38887508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with bisacodyl, picosulfate and prokinetics. Physiopathology and diagnosis of constipation].
    Müller-Lissner S
    Pharm Unserer Zeit; 2008; 37(2):130-4. PubMed ID: 18293319
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis.
    Nelson AD; Camilleri M; Chirapongsathorn S; Vijayvargiya P; Valentin N; Shin A; Erwin PJ; Wang Z; Murad MH
    Gut; 2017 Sep; 66(9):1611-1622. PubMed ID: 27287486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Use of Bisacodyl in Pediatric Functional Constipation Refractory to Conventional Therapy.
    Bonilla S; Nurko S; Rodriguez L
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):288-291. PubMed ID: 32459741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.
    Corsetti M; Landes S; Lange R
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14123. PubMed ID: 33751780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study.
    Katz PO; Rex DK; Epstein M; Grandhi NK; Vanner S; Hookey LC; Alderfer V; Joseph RE
    Am J Gastroenterol; 2013 Mar; 108(3):401-9. PubMed ID: 23318484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based treatment recommendations for OTC management of chronic constipation.
    Rao SSC; Brenner DM
    J Am Assoc Nurse Pract; 2022 Sep; 34(9):1041-1044. PubMed ID: 35943487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments.
    Müller-Lissner S
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):391-401. PubMed ID: 23425050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review.
    Alsalimy N; Madi L; Awaisu A
    J Clin Pharm Ther; 2018 Oct; 43(5):595-605. PubMed ID: 29885259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisacodyl as laxative in Belgian pharmacy].
    De Braekeleer K; Vandersteen L
    J Pharm Belg; 2016 Jun; (2):4-9. PubMed ID: 30281225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylene Glycol- or Sodium Picosulphate-Based Laxatives Before Colonoscopy in Children.
    Vejzovic V; Wennick A; Idvall E; Agardh D; Bramhagen AC
    J Pediatr Gastroenterol Nutr; 2016 Mar; 62(3):414-9. PubMed ID: 26360658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concomitant use of an osmotic laxative, magnesium sulphate, and a stimulant laxative, bisacodyl, does not enhance the laxative effect.
    Ikarashi N; Mimura A; Kon R; Iizasa T; Omodaka M; Nagoya C; Ishii M; Toda T; Ochiai W; Sugiyama K
    Eur J Pharm Sci; 2012 Jan; 45(1-2):73-8. PubMed ID: 22085681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.